Thus, it may be relevant to study the regulatory mechanisms (e.g., transcription factor binding) and clinical behavior (e.g., response to androgen deprivation or chemotherapy) in those 20 percentage of PCa with increased IGF2 expression in more detail. This evidence concerns the gene IGF2 and posterior cortical atrophy.